Prairie Cancer Consortium leadership and members share updates with the Network

On Wednesday, October 14, 2025, leadership and researchers from the Prairie Cancer Consortium presented their work to Network members as part of the MOHCCN seminar series. 

This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. 

This event was co-chaired by Christine Wu a member of the MOHCCN Patient Working Group, and by Véronique LeBlanc, PhD, Program Manager and Scientific Writer, TFRI.

Watch the full video

Speakers

Consortium Activities Update

Jennifer Chan, MD - Associate Professor, Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary; Director, Arnie Charbonneau Cancer Institute; MOHCCN consortium lead (PR2C)

Research Presentations

Use of precision preclinical models to facilitate precision oncology in gynecologic tract cancer

Cheng-Han Lee, MD, PhD - Pathologist, Royal Alexandra Hospital; Associate professor, Department of Laboratory Medicine & Pathology, Faculty of Medicine & Dentistry, University of Alberta

Multi-omic Dissection of Lymph Node Metastasis in Oral Squamous Cell Carcinoma

Ayan Chanda, MTech., PhD - Postdoctoral associate, Pinaki Bose lab, Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary

• View scientific and plain language abstracts